Drug Research
Catalent Partners with ViralClear Pharmaceuticals on Potential Treatment for COVID-19
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced...
Drug Research
Calypso Biotech Completes CALY-002 Clinical Batch Manufacturing
AGC Biologics, a global biopharmaceutical Contract Development Manufacturing Organization (CDMO), produces a GMP-grade clinical batch of CALY-002 for Calypso Biotech. The immunotherapy biotech company retained...
Drug Research
Cobra signs supply agreement with AstraZeneca for manufacture of COVID-19 vaccine candidate
Cobra Biologics, part of the Cognate BioServices family, an international CDMO for biologics and pharmaceuticals, announced it has signed a supply agreement with AstraZeneca UK...
Drug Research
Neurocrine and Takeda Ink $2 Billion-Plus Neuroscience Development Deal
San Diego-based Neurocrine Biosciences is partnering with Japan’s Takeda Pharmaceutical to develop and commercialize molecules in Takeda’s early-to-mid-stage psychiatry pipeline. Takeda granted an exclusive license...
Drug Research
Saiba AG Selects AGC Biologics to Develop and Produce COVID-19 Vaccine
AGC Biologics, a global biopharmaceutical Contract Development Manufacturing Organization (CDMO), has announced it will be partnering with Saiba AG to manufacture a SARS-CoV-2 vaccine to...
Drug Research
Catalent Signs Agreement with AstraZeneca to Manufacture COVID-19 Vaccine Candidate
Catalent, Inc. , the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health...
Drug Research
Fujifilm to invest 100 billion yen to expand its large scale biologics production facility in Denmark
FUJIFILM Corporation will make a major capital investment of approximately 100 billion yen (928 million USD) in the Denmark site of FUJIFILM Diosynth Biotechnologies, a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.